γ-aminobutyric acid receptor B signaling drives glioblastoma in females in an immune-dependent manner.
Ontology highlight
ABSTRACT: Sex differences in immune responses impact cancer outcomes and treatment response, including in glioblastoma (GBM). However, host factors underlying sex specific immune-cancer interactions are poorly understood. Here, we identify the neurotransmitter γ-aminobutyric acid (GABA) as a driver of GBM-promoting immune response in females. We demonstrated that GABA receptor B (GABBR) signaling enhances L-Arginine metabolism and nitric oxide synthase 2 (NOS2) expression in female granulocytic myeloid-derived suppressor cells (gMDSCs). GABBR agonist and GABA analog promoted GBM growth in females in an immune-dependent manner, while GABBR inhibition reduces gMDSC NOS2 production and extends survival only in females. Furthermore, female GBM patients have enriched GABA transcriptional signatures compa
SUBMITTER: Pathak A
PROVIDER: S-EPMC11291093 | biostudies-literature | 2024 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA